financetom
Business
financetom
/
Business
/
Opyn Health, Inc. Acquires Empara's AI-driven Benefits Engagement Platform to Deliver a Comprehensive, Integrated Benefits Experience
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Opyn Health, Inc. Acquires Empara's AI-driven Benefits Engagement Platform to Deliver a Comprehensive, Integrated Benefits Experience
Oct 22, 2025 6:07 AM

Expanded capabilities position Opyn to elevate the self-funded experience through a seamless, end-to-end benefits administration solution.

CONSHOHOCKEN, Pa., Oct. 22, 2025 /PRNewswire/ -- Opyn Health, Inc., a leader in price transparency, virtual care, and provider directory services, announced the successful acquisition of Empara, a pioneering AI-led benefits engagement and administration platform.

The acquisition advances a shared mission to make healthcare simple by pairing Empara's powerful AI platform and member app with Opyn's robust product portfolio and deep data capabilities.

"There is a digital deficit in the self-funded insurance market; administrative systems are redundant and antiquated, and the number of solutions and portals is confusing for members," said Richard Fuchs, CEO and board chair at Opyn. "By combining Opyn's member solutions with Empara's intelligent engagement and administration platform, we are creating a single, intuitive access point for healthcare that saves time and money for members, plans, and administrators."

With the combined platform, members will benefit from a unified, AI-driven interface that brings all their healthcare tools together for a seamless experience. For administrators, the integration enables scalable, efficient operations—reducing manual work, enhancing service quality, and paving the path to sustainable profitability.

"Joining Opyn gives us the chance to do something more impactful than either of us could do alone," said Markus Waite, President of Empara. "Together, we're creating a more connected healthcare experience that empowers people to take control of their benefits. This is about building a tech-enabled future where clarity, access, and trust replace the complexity that has long burdened the system." The combined company's core offerings will be offered to third-party administrators (TPAs), brokers, and self-insured employers, PEOs, MEC plans and other alternative healthcare solutions.

Empara was launched within the Goodroot community, which builds and accelerates healthcare startups committed to making care more affordable and accessible.

Empara founders Markus Waite, Ben Callaghan, and Mike Nigels will join Opyn Health, applying their AI expertise to unlock new potential within Opyn's rich network pricing data and digital health services.

About Opyn Health, Inc.: Opyn Health is a healthcare technology company dedicated to making healthcare easy through price transparency, virtual care, and provider directory solutions. Opyn partners with health plans, administrators, and employers to deliver tools that empower members, streamline operations, and reduce costs across the healthcare ecosystem.

About Empara: Empara is an AI-powered engagement platform designed to simplify and modernize benefits engagement and administration. By combining intelligent automation with user-friendly design, Empara enables administrators and health plans to eliminate inefficiencies, improve member engagement, and create a more connected healthcare experience.

Media Contact:

Courtney Paulson

703-618-3341

[email protected] 

View original content to download multimedia:https://www.prnewswire.com/news-releases/opyn-health-inc-acquires-emparas-ai-driven-benefits-engagement-platform-to-deliver-a-comprehensive-integrated-benefits-experience-302590932.html

SOURCE Opyn Health

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Exxon Mobil Signs Memorandum of Understanding With EV Battery Developer SK On for Lithium
Exxon Mobil Signs Memorandum of Understanding With EV Battery Developer SK On for Lithium
Jun 25, 2024
10:23 AM EDT, 06/25/2024 (MT Newswires) -- Exxon Mobil ( XOM ) said Tuesday it signed a nonbinding memorandum of understanding with electric vehicle battery developer SK On, potentially paving the way to securing a multiyear offtake deal of up to 100,000 metric tons of Mobil Lithium from the company's first planned project in Arkansas. SK On intends to use...
Tempus, United Therapeutics Launch Collaboration to Use AI to Detect Risk of Pulmonary Hypertension
Tempus, United Therapeutics Launch Collaboration to Use AI to Detect Risk of Pulmonary Hypertension
Jun 25, 2024
10:22 AM EDT, 06/25/2024 (MT Newswires) -- Tempus AI ( TEM ) said Tuesday it is launching a collaboration with United Therapeutics ( UTHR ) under which Tempus will develop artificial intelligence-backed medical device software to detect people at risk of having pulmonary hypertension. Financial details of the collaboration weren't disclosed. Tempus said it built an algorithm that analyzes the...
Deere Insider Sold Shares Worth $5,048,913, According to a Recent SEC Filing
Deere Insider Sold Shares Worth $5,048,913, According to a Recent SEC Filing
Jun 25, 2024
10:24 AM EDT, 06/25/2024 (MT Newswires) -- Cory J Reed, President, Agriculture & Turf Division for Production & Precision Ag, on June 24, 2024, sold 13,370 shares in Deere (DE) for $5,048,913. Following the Form 4 filing with the SEC, Reed Cory J has control over a total of 41,642 shares of the company, with 41,642 shares held directly. SEC...
--Street Color: Eli Lilly Partners With OpenAI for Developing Antimicrobials to Treat Drug-Resistant Bacteria
--Street Color: Eli Lilly Partners With OpenAI for Developing Antimicrobials to Treat Drug-Resistant Bacteria
Jun 25, 2024
10:18 AM EDT, 06/25/2024 (MT Newswires) -- Price: 899.28, Change: +9.17, Percent Change: +1.03 ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved